Kirkpatrick · International journal of radiation oncology, biology, physics 2004 · preclinical animal study and computational simulation · n=?

Predicting the effect of temporal variations in PO2 on tumor radiosensitivity.

Cited 45 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Preclinical rodent tissue oxygenation measurements combined with mathematical modeling.

PubMed 15183486 · doi:10.1016/j.ijrobp.2004.02.015 · record verified 2026-08-26

What was done

Researchers measured PO2 over 50–60 minutes at multiple sites in rat fibrosarcomas, 9L gliomas, and R3230Ac mammary adenocarcinomas. These measurements were converted into oxygen enhancement ratios (OERs) using an established empirical correlation. The authors developed a computational model treating tumors as 10^3 to 10^4 independent oxygenation subvolumes with randomized starting points on OER-time curves to calculate oxygen effective dose (OED) distributions and tumor control probabilities (TCPs) for conventionally fractionated external beam radiotherapy (EBRT), stereotactic radiosurgery (SRS), and intraoperative radiotherapy (IORT).

What was found

OER ranged from 1 to 3 across measured PO2 levels, with mean OER between 1.6 and 2.6; temporal variation in OER was greater at lower PO2 levels. The standard deviation of OED was small for EBRT (<2%), but substantially higher for SRS and IORT (3% to 6%), with the largest variations at the lowest PO2 levels. Compared with uniform oxygenation of equivalent mean OED, TCP was minimally affected in EBRT or well-oxygenated tumors, whereas temporal PO2 variations in hypoxic tumors produced a significant decrease in TCP for SRS and IORT.

Why it matters

This modeling suggests that transient fluctuations in tumor oxygenation matter far more for single-fraction or hypofractionated radiotherapy regimens than for conventionally fractionated therapy, potentially explaining lower-than-expected tumor control in hypoxic tumors treated with SRS or IORT.

Limits

The findings derive from a theoretical mathematical simulation informed by rodent tumor measurements rather than human clinical outcomes. The abstract does not specify the sample size (number of animals or tumors). The model assumes independent oxygenation subvolumes and relies on historical in vitro OER conversion curves, which may not capture full in vivo tumor biology.

Cited by